查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1864512

抛弃式产品市场（按产品类型、应用、最终用户、血液成分、材料和销售管道划分）－2025-2032年全球预测

Blood Processing Disposables Market by Product Type, Application, End User, Blood Component, Material, Sales Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，血液处理抛弃式市场规模将达到 293.6 亿美元，复合年增长率为 11.04%。

主要市场统计数据
基准年 2024 126.9亿美元
预计年份：2025年 141亿美元
预测年份：2032年 293.6亿美元
复合年增长率 (%) 11.04%

一个权威的框架，阐述了影响医疗机构中一次性血液处理抛弃式产品的临床、监管和供应链动态。

抛弃式产品市场处于临床需求、生产精度和监管监督三者交汇点。血袋、离心机套件、采集套装、过滤装置和输血套装等设备对于包括血液采集、分离和输血在内的众多临床环节至关重要。这些产品构成了血库、诊断实验室和医院提供服务的基础，形成了一个相互关联的生态系统，对可靠性和可追溯性提出了极高的要求。

临床自动化、材料创新、监管可追溯性和永续性压力等多种因素正在重塑一次性用品的市场结构和供应商策略。

过去几年，临床实践、供应链结构和创新模式发生了一系列变革性变化，这些变化共同重塑了血液处理抛弃式市场。首先，临床工作流程越来越重视自动化和封闭式系统设计，以降低污染风险并简化劳动密集任务。自动化离心套件和自动化分离技术因其能够标准化输出并提高处理量而备受关注。其次，从先进聚合物到改良阻隔膜，材料的创新使得设备具有更高的储存稳定性和更强的生物相容性，为低温运输管理和敏感成分的长期储存开闢了新的可能性。

从 2025 年开始的新关税趋势将迫使一次性产品和销售管道的公司重新分配成本、转移製造地并实现采购多元化。

2025年关税表更新及贸易政策调整的实施，为在美国营运或从美国采购的製造商、经销商和采购团队带来了许多复杂挑战。关税变化影响整个产品系列的到岸成本，包括初级和次级血袋、自动和手动离心机套件、采血套装（包括配件和完整套装）、过滤装置（例如白血球去除过滤器和病原体去除过滤器）以及从定製到标准配置的各种输血套装。这些成本压力会影响不同的市场管道，因为直销团队和第三方经销商面临的利润率敏感度和合约限制各不相同。

细分市场层面的洞察揭示了产品差异、临床应用、最终用户、组件特定处理、材料和销售管道如何决定商业性和监管方面的优先事项。

细緻的细分方法揭示了产品、应用、最终用户、血液成分、材料和销售管道等各个维度上的差异化价值驱动因素和营运需求。在产品层面，血袋及其主要和辅助配置与离心套件有所区别，后者提供自动化和手动两种形式。采血套装涵盖从配件到完整解决方案的各种产品，过滤装置根据白血球去除和病原体去除功能进行区分，输血套装则从客製化解决方案到标准化产品进行分类。应用层面的细分区分了采血工作流程和分离输血工作流程。分离过程本身又分为自动化和手动两种，每种方式所需的设备、人员配备和品管要求各不相同。

临床应用、监管复杂性和生产重点方面的区域差异，要求在美洲、欧洲、中东、非洲和亚太地区制定量身定制的市场进入策略。

区域特征对美洲、欧洲、中东和非洲以及亚太地区的创新采纳、监管时间表和采购行为有显着影响。在美洲，集中式血库网路和一体化医院系统催生了对可扩展、高通量一次性系统的需求，促使供应商投资快速物流和本地认证。同时，在欧洲、中东和非洲地区，不同的管理体制和采购模式使得遵守各种标准、在地化标籤以及与当地经销商伙伴关係对于市场准入和持续推广至关重要。

在竞争激烈的环境中，能够提供可靠性和临床价值的整合解决方案提供者、技术专家和本地化响应型製造商将更具优势。

血液处理抛弃式领域的竞争格局呈现出多元化的格局，既有产品系列丰富的全球领导企业，也有专注于先进过滤和自动化分离技术的利基企业，还有利用本地抛弃式和分销网络的区域性参与企业。主要企业强调提供整合解决方案，将与耗材相容的设备、品管系统和服务结合，从而建立客户层面的长期合作关係。而专业企业则透过专有的过滤介质、先进的聚合物配方或一次性自动化模组来应对特定的临床挑战，例如提高白血球去除效率或病原体减少，从而实现差异化竞争。

为取得竞争优势，可采取切实可行的策略步骤，整合产品模组化、采购弹性、自动化、通路平衡与永续性。

产业领导者应采取多维策略，将产品开发、供应链韧性和商业性执行与不断变化的临床需求和市场现实相协调。首先，应优先考虑模组化和可扩展的产品设计，以便在主采血袋和卫星采血袋、自动和手动离心套件、配件和全套采血设备以及白血球去除和病原体去除过滤装置之间快速重新配置。这种设计灵活性可缩短针对不同地区的产品上市时间，并提高对临床医师回馈的应对力。

透明的混合方法研究过程，结合技术审查和相关人员访谈，以稳健的三角验证检验营运和商业见解。

我们的研究途径结合了对技术文献、监管申报文件和已发布的临床指南的系统性回顾，以及定性的初步研究，以检验营运和商业方面的见解。二次分析着重于与血袋、离心机套件、采集套装、过滤装置和输血套装相关的设备规格、材料属性资料和监管指南，以及影响采集、分离和输血流程的政策。此外，我们还开展了一项初步调查计画，包括对血库采购人员、检查室经理、负责输血服务的临床医生以及生产和分销机构的高管进行访谈，以获得关于实施挑战和驱动因素的第一手资料。

概述产品差异化、采购弹性、法规遵循和区域专业化如何将技术进步转化为临床和营运价值。

总之，血液处理抛弃式产品领域正处于一个转折点，临床对安全性和效率的需求与供应链压力以及不断变化的监管要求交织在一起。产品层面的差异化——例如血袋、离心机套件、采血针、过滤装置和输血针——越来越体现在自动化能力、材料性能和地理市场进入等方面。从血库到诊断实验室再到医院，终端使用者将优先选择那些能够证明其产品可降低污染风险、改善操作人体工学设计并在动态的价格和物流环境下提供可靠供应的供应商。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 用于血袋库存和储存管理的整合式数位追踪系统
  • 开发封闭式采血装置以最大限度降低污染风险
  • 引入病原体减少一次性试剂盒以提高血液製品的安全性
  • 提高输血中心对即用型一次性白血球去除过滤器的偏好
  • 用于快速床边血液分析的微流体一次性试剂盒的进展
  • 监管重点在于一次性血液管路组件的灭菌验证。
  • 扩大在抛弃式产品製造中使用可生物降解和环保材料的范围
  • 与医疗设备製造商和一家生物製药公司合作，开发客製化的一次性血液分离器
  • 将具备RFID功能的耗材整合到一次性产品中，用于即时监测血液成分的使用情况。
  • 对冷冻干燥血浆袋和一次性復溶试剂盒的需求激增

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的血液处理抛弃式产品市场

  • 血袋
    • 主要包
    • 卫星套件
  • 离心试剂盒
    • 汽车套件
    • 手册套件
  • 采血套装
    • 配件套装
    • 全套
  • 过滤装置
    • 白血球去除过滤器
    • 病原体去除过滤器
  • 运输套装
    • 自订套装
    • 标准集

9. 按应用分類的血液处理抛弃式产品市场

  • 血液收集
  • 分离
    • 自动分离
    • 人工分离
  • 输血

第十章 以最终用户分類的血液处理抛弃式产品市场

  • 血库
  • 诊断实验室
  • 医院

第十一章 依血液成分分類的抛弃式产品市场

  • 电浆
    • 冷沉淀物
    • 新鲜冷沉淀物
  • 血小板
  • 红血球
  • 全血

第十二章 按材料分類的血液处理抛弃式产品市场

  • 聚丙烯
  • PVC
  • 硅

第十三章 血液处理抛弃式产品市场（依销售管道划分）

  • 直销
  • 批发商

14. 各地区血液处理抛弃式产品市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 血液处理抛弃式产品市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 各国血液处理抛弃式产品市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Terumo Corporation
    • Fresenius Kabi AG
    • Baxter International Inc.
    • Grifols SA
    • Haemonetics Corporation
    • Becton Dickinson and Company
    • Pall Corporation
    • Macopharma SA
    • Terumo BCT, Inc.
    • Cerus Corporation
Product Code: MRR-F97DD5A7E121

The Blood Processing Disposables Market is projected to grow by USD 29.36 billion at a CAGR of 11.04% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 12.69 billion
Estimated Year [2025] USD 14.10 billion
Forecast Year [2032] USD 29.36 billion
CAGR (%) 11.04%

An authoritative framing of clinical, regulatory, and supply chain dynamics that shape blood processing disposables across care settings

The blood processing disposables landscape sits at the intersection of clinical necessity, manufacturing precision, and regulatory scrutiny. Devices such as blood bags, centrifugation kits, collection sets, filtration devices, and transfer sets are integral to a wide spectrum of clinical pathways including collection, separation, and transfusion. In turn, these products underpin services delivered by blood banks, diagnostic laboratories, and hospitals, creating an interconnected ecosystem that demands high reliability and traceability.

Technological advances, evolving clinical protocols, and materials science improvements have steadily raised performance and safety standards. Simultaneously, supply chain dynamics and regulatory expectations have imposed new layers of complexity for manufacturers and procurement teams. Given the critical nature of blood handling, even incremental gains in device safety, handling ergonomics, or sterilization assurance translate into meaningful clinical and operational improvements. This introduction frames the fundamental dynamics that the subsequent sections unpack in greater technical and commercial detail.

Converging clinical automation, materials innovation, regulatory traceability, and sustainability pressures are reshaping the disposables landscape and supplier strategies

The last several years have witnessed transformative shifts across clinical practice, supply chain architecture, and innovation models that collectively redefine the blood processing disposables market. First, clinical workflows increasingly prioritize automation and closed-system designs to reduce contamination risk and streamline labor-intensive tasks; automated centrifugation kits and automated separation techniques are gaining attention for their capacity to standardize outputs and improve throughput. Second, materials innovation - from advanced polymers to improved barrier films - has enabled devices with longer shelf stability and enhanced biocompatibility, creating new possibilities for cold chain management and extended storage of sensitive components.

Concurrently, procurement strategies have evolved toward supplier consolidation and vendor-managed inventory to mitigate disruption risk and control cost. Regulatory authorities have raised expectations for post-market surveillance and traceability, prompting manufacturers to embed serialization and data capture capabilities into disposables. Finally, sustainability considerations are nudging design choices toward recyclable or lower-impact materials and processes, while also driving interest in devices that minimize waste through multi-functionality or modularity. Together, these shifts are realigning competitive positioning, investment priorities, and adoption timelines across the ecosystem.

New 2025 tariff dynamics are forcing cost reallocation, regional manufacturing shifts, and sourcing diversification across the full disposables product and channel spectrum

The introduction of updated tariff schedules and trade policy adjustments in 2025 has introduced tangible complexity for manufacturers, distributors, and procurement teams operating in or sourcing from the United States. Tariff changes affect landed costs across the product portfolio - blood bags including primary and satellite variants, centrifugation kits both automated and manual, collection sets whether accessory or complete, filtration devices such as leukocyte reduction and pathogen reduction filters, and transfer sets that range from custom to standard configurations. These cost pressures cascade differently depending on the route to market, as direct sales operations and third-party distributors each face distinct margin sensitivities and contractual constraints.

In response, supply chain managers and commercial leaders are recalibrating sourcing strategies, exploring regionalization of production, and negotiating longer-term contracts to stabilize input cost exposure. Some manufacturers are accelerating qualification of alternate suppliers for key materials like polypropylene, PVC, and silicone to diversify risk, while others are revisiting transfer pricing, inventory buffers, and logistics routing to optimize total landed costs. The tariff environment also amplifies the value of localized manufacturing capacity in the Americas and in other strategic regions, since proximity can reduce the tariff burden and improve service levels for end users such as blood banks, diagnostic laboratories, and hospitals. Ultimately, the interplay between tariffs, product complexity, and channel structure will determine which players can preserve competitiveness and which will need to adapt commercial models to maintain access to the US market.

Segment-level insights reveal how product variants, clinical applications, end users, component-specific handling, materials, and sales channels determine commercial and regulatory priorities

A nuanced segmentation approach reveals differentiated value drivers and operational requirements across product, application, end-user, blood component, material, and sales channel dimensions. Product-level distinctions separate Blood Bags and their primary and satellite configurations from Centrifugation Kits offered in automated and manual formats, while Collection Sets span accessory and complete solutions; Filtration Devices vary between leukocyte reduction and pathogen reduction capabilities, and Transfer Sets range from custom-engineered solutions to standardized offerings. Application segmentation distinguishes Collection from Separation and Transfusion workflows, with Separation itself bifurcated into automated and manual processes that have divergent equipment, staffing, and quality control implications.

End users include Blood Banks that emphasize throughput, traceability, and long-term storage compatibility; Diagnostic Laboratories that prioritize specimen integrity, chain-of-custody, and throughput for testing workflows; and Hospitals that require reliable, on-demand disposables for both routine and emergency transfusion pathways. Blood Component segmentation highlights plasma offerings such as cryoprecipitate and fresh frozen plasma, platelets, red blood cells, and whole blood, each with unique handling, filtration, and storage demands that influence product design and validation. Material choices - polypropylene, PVC, and silicone - drive compatibility with sterilization methods, shelf life, and regulatory filing strategies, while sales channels split between Direct and Distributor routes, shaping service models, contract terms, and post-sale support obligations. When viewed collectively, this segmentation underscores that product development, regulatory strategy, and commercial execution must be aligned to the specific clinical and operational contexts of target customers.

Regional variation in clinical adoption, regulatory complexity, and manufacturing priorities requires tailored market access strategies across the Americas, EMEA, and Asia-Pacific

Regional dynamics exert strong influence on innovation adoption, regulatory timelines, and procurement behavior across the Americas, Europe, Middle East & Africa, and Asia-Pacific regions. In the Americas, centralized blood bank networks and integrated hospital systems create demand for scalable, high-throughput disposable systems and incentivize suppliers to invest in quick-response logistics and domestic qualification. Conversely, Europe, the Middle East & Africa presents a mosaic of regulatory regimes and procurement models where conformity to diverse standards, localization of labeling, and regional distributor partnerships are critical to market access and sustained uptake.

Asia-Pacific is characterized by rapid capacity expansion, heterogeneous clinical infrastructure, and an accelerating push toward automation in higher-volume centers, which together create opportunities for both global incumbents and regional manufacturers. Transitioning between these regional realities requires suppliers to balance global product platforms with configurable localization, invest in region-specific clinical validation, and cultivate distributor or hospital system relationships that can bridge regulatory and logistical barriers. Moreover, cross-border trade considerations, tariff regimes, and local manufacturing incentives will continue to shape where and how suppliers prioritize capital allocation and commercial focus.

Competitive dynamics reward integrated solution providers, technical specialists, and regionally agile manufacturers that demonstrate reliability and clinical value

Competitive dynamics in the blood processing disposables sector are defined by a mix of global incumbents with broad product portfolios, specialized niche manufacturers focused on advanced filtration or automated separation technologies, and regional players who leverage localized production and distributor networks. Leading organizations emphasize integrated solutions that combine disposables with compatible instrumentation, quality management systems, and service offerings to lock in account-level relationships. Meanwhile, specialist firms differentiate through proprietary filtration media, advanced polymer formulations, or single-use automation modules that address specific clinical pain points such as leukocyte reduction efficiency or pathogen mitigation.

Strategic partnerships and M&A remain common approaches for scaling capabilities, accelerating market entry into new geographies, or complementing product portfolios with adjacent technologies. Companies that excel at regulatory harmonization, robust post-market surveillance, and rapid field support secure preferential status with high-volume blood banks and hospital systems. Additionally, investments in manufacturing flexibility, including configurable transfer sets and customizable collection set assemblies, allow suppliers to respond quickly to clinician preferences and procurement tenders. Collectively, the competitive landscape rewards technical differentiation, supply reliability, and the ability to demonstrate measurable clinical and operational benefits to end users.

Practical strategic steps for leaders to align product modularity, sourcing resilience, automation, channel balance, and sustainability to secure competitive advantage

Industry leaders should adopt a multi-dimensional strategy that aligns product development, supply chain resilience, and commercial execution with evolving clinical needs and trade realities. First, prioritize modular and scalable product designs that allow for rapid configuration between primary and satellite blood bags, automated and manual centrifugation kits, accessory and complete collection sets, and both leukocyte reduction and pathogen reduction filtration devices. This design flexibility reduces time-to-market for localized variants and improves responsiveness to clinician feedback.

Second, diversify material sourcing for critical polymers such as polypropylene, PVC, and silicone, and qualify alternate suppliers across multiple regions to reduce exposure to tariff-driven cost volatility. Third, invest in automation and closed-system workflows that support both automated and manual separation use cases, enabling end users to standardize procedures and improve traceability. Fourth, strengthen distributor relationships in complex regulatory regions while maintaining direct sales capabilities in high-volume systems to balance margin, control, and service requirements. Finally, incorporate sustainability targets into product roadmaps and packaging strategies to meet procurement criteria and public-sector tender priorities, while documenting lifecycle impacts to support procurement decisions.

A transparent mixed-methods research process combining technical review and stakeholder interviews to validate operational and commercial insights with robust triangulation

The research approach combined a structured review of technical literature, regulatory filings, and publicly available clinical guidance with qualitative primary research to validate operational and commercial insights. Secondary analysis focused on device specifications, material property data, and standards guidance relevant to blood bags, centrifugation kits, collection sets, filtration devices, and transfer sets, as well as policies that affect collection, separation, and transfusion workflows. To complement this, the primary research program included interviews with senior procurement leaders from blood banks, laboratory managers, clinicians overseeing transfusion services, and executives from manufacturer and distributor organizations to surface first-hand perspectives on pain points and adoption drivers.

Data validation employed triangulation across sources, cross-referencing product claims with regulatory summaries and clinician feedback to ensure practical relevance. Where possible, lifecycle and materials compatibility discussions were corroborated through technical white papers and manufacturer technical dossiers. The methodology emphasized transparency in assumptions, traceability of qualitative inputs, and iterative validation of emerging themes, ensuring that the conclusions reflect grounded, actionable observations rather than speculative projections.

Concluding synthesis of how product differentiation, sourcing resilience, regulatory alignment, and regional focus convert technical advances into clinical and operational value

In conclusion, the blood processing disposables domain is at an inflection point where clinical demand for safety and efficiency intersects with supply chain pressures and evolving regulatory expectations. Product-level differentiation across blood bags, centrifugation kits, collection sets, filtration devices, and transfer sets will increasingly be interpreted through the lenses of automation capability, materials performance, and regional market access. End users from blood banks to diagnostic laboratories and hospitals will favor suppliers that can demonstrably reduce contamination risk, improve handling ergonomics, and ensure reliable availability under shifting tariff and logistics conditions.

Forward-looking organizations that integrate design modularity, diversified sourcing, and strong post-market support will find themselves better positioned to capture operational partnerships with high-volume centers. At the same time, the ability to localize production and adapt to region-specific regulatory and procurement nuances will determine market entry success across the Americas, Europe, Middle East & Africa, and Asia-Pacific. These coordinated efforts will enable stakeholders to convert technical advancements into measurable clinical and operational value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of digital tracking systems for blood bag inventory and chain of custody management
  • 5.2. Development of closed system blood collection sets to minimize contamination risks
  • 5.3. Adoption of pathogen reduction disposable kits for improved blood product safety
  • 5.4. Growing preference for ready-to-use disposable leukoreduction filters in transfusion centers
  • 5.5. Advancements in microfluidic disposable cartridges for rapid bedside blood analysis
  • 5.6. Regulatory emphasis on sterilization validation of single-use blood tubing assemblies
  • 5.7. Expansion of biodegradable and ecofriendly materials in blood processing disposables manufacturing
  • 5.8. Collaboration between device makers and biopharma for bespoke disposable blood separators
  • 5.9. Integration of RFID-enabled disposables for real-time monitoring of blood component usage
  • 5.10. Surge in demand for freeze-dried plasma bags and single-use reconstitution kits

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Processing Disposables Market, by Product Type

  • 8.1. Blood Bags
    • 8.1.1. Primary Bags
    • 8.1.2. Satellite Bags
  • 8.2. Centrifugation Kits
    • 8.2.1. Automated Kits
    • 8.2.2. Manual Kits
  • 8.3. Collection Sets
    • 8.3.1. Accessory Sets
    • 8.3.2. Complete Sets
  • 8.4. Filtration Devices
    • 8.4.1. Leukocyte Reduction Filter
    • 8.4.2. Pathogen Reduction Filter
  • 8.5. Transfer Sets
    • 8.5.1. Custom Sets
    • 8.5.2. Standard Sets

9. Blood Processing Disposables Market, by Application

  • 9.1. Collection
  • 9.2. Separation
    • 9.2.1. Automated Separation
    • 9.2.2. Manual Separation
  • 9.3. Transfusion

10. Blood Processing Disposables Market, by End User

  • 10.1. Blood Bank
  • 10.2. Diagnostic Laboratory
  • 10.3. Hospital

11. Blood Processing Disposables Market, by Blood Component

  • 11.1. Plasma
    • 11.1.1. Cryoprecipitate
    • 11.1.2. Fresh Frozen Plasma
  • 11.2. Platelet
  • 11.3. Red Blood Cell
  • 11.4. Whole Blood

12. Blood Processing Disposables Market, by Material

  • 12.1. Polypropylene
  • 12.2. PVC
  • 12.3. Silicone

13. Blood Processing Disposables Market, by Sales Channel

  • 13.1. Direct
  • 13.2. Distributor

14. Blood Processing Disposables Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Blood Processing Disposables Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Blood Processing Disposables Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Terumo Corporation
    • 17.3.2. Fresenius Kabi AG
    • 17.3.3. Baxter International Inc.
    • 17.3.4. Grifols S.A.
    • 17.3.5. Haemonetics Corporation
    • 17.3.6. Becton Dickinson and Company
    • 17.3.7. Pall Corporation
    • 17.3.8. Macopharma SA
    • 17.3.9. Terumo BCT, Inc.
    • 17.3.10. Cerus Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. BLOOD PROCESSING DISPOSABLES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. BLOOD PROCESSING DISPOSABLES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BLOOD PROCESSING DISPOSABLES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRIMARY BAGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRIMARY BAGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRIMARY BAGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRIMARY BAGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRIMARY BAGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRIMARY BAGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SATELLITE BAGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SATELLITE BAGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SATELLITE BAGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SATELLITE BAGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SATELLITE BAGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SATELLITE BAGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY ACCESSORY SETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY ACCESSORY SETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY ACCESSORY SETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY ACCESSORY SETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY ACCESSORY SETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY ACCESSORY SETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COMPLETE SETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COMPLETE SETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COMPLETE SETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COMPLETE SETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COMPLETE SETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COMPLETE SETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PATHOGEN REDUCTION FILTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PATHOGEN REDUCTION FILTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PATHOGEN REDUCTION FILTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PATHOGEN REDUCTION FILTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PATHOGEN REDUCTION FILTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PATHOGEN REDUCTION FILTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CUSTOM SETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CUSTOM SETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CUSTOM SETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CUSTOM SETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CUSTOM SETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CUSTOM SETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY STANDARD SETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY STANDARD SETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY STANDARD SETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY STANDARD SETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY STANDARD SETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY STANDARD SETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED SEPARATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED SEPARATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED SEPARATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED SEPARATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED SEPARATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY AUTOMATED SEPARATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL SEPARATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL SEPARATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL SEPARATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL SEPARATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL SEPARATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MANUAL SEPARATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BANK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BANK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BANK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BANK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BANK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BANK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CRYOPRECIPITATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CRYOPRECIPITATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CRYOPRECIPITATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CRYOPRECIPITATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CRYOPRECIPITATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CRYOPRECIPITATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FRESH FROZEN PLASMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FRESH FROZEN PLASMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FRESH FROZEN PLASMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FRESH FROZEN PLASMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FRESH FROZEN PLASMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FRESH FROZEN PLASMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLATELET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLATELET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLATELET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLATELET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLATELET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLATELET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY RED BLOOD CELL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY RED BLOOD CELL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY RED BLOOD CELL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY RED BLOOD CELL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY RED BLOOD CELL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY RED BLOOD CELL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PVC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PVC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PVC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PVC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PVC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PVC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SILICONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SILICONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SILICONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SILICONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SILICONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIRECT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIRECT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIRECT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIRECT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIRECT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DIRECT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2018-2024 (USD MILLION)
  • TABLE 270. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COLLECTION SETS, 2025-2032 (USD MILLION)
  • TABLE 275. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 276. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY FILTRATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2018-2024 (USD MILLION)
  • TABLE 278. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY TRANSFER SETS, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SEPARATION, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PLASMA, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2018-2024 (USD MILLION)
  • TABLE 298. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY BLOOD BAGS, 2025-2032 (USD MILLION)
  • TABLE 299. LATIN AMERICA BLOOD PROCESSING DISPOSABLES MARKET SIZE, BY CENTRIFUGATION KITS, 2018-2024 (USD MILLION)
  • TABLE 300. LAT